|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q43239465
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010717.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q43239465
|
|
024
|
|
|
‡a
0000-0001-5799-8404
‡2
orcid
|
|
024
|
|
|
‡a
35880539100
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q43239465
|
|
100
|
0 |
|
‡a
Rita Machado
‡c
researcher
‡9
en
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Rita Machado
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's In-vivo evaluation of prolonged release bilayer tablets of anti-Parkinson drugs in Göttingen minipigs
|
|
670
|
|
|
‡a
Author's Pharmacokinetic-pharmacodynamic interaction between BIA 3-202, a novel COMT inhibitor, and levodopa/benserazide
|
|
670
|
|
|
‡a
Author's Pharmacokinetic-pharmacodynamic interaction between BIA 3-202, a novel COMT inhibitor, and levodopa/carbidopa
|
|
670
|
|
|
‡a
Author's Pharmacokinetic-pharmacodynamic interaction between nebicapone, a novel catechol-o-methyltransferase inhibitor, and controlled-release levodopa/carbidopa 200 mg/50 mg: randomized, double-blind, placebo-controlled, crossover study in healthy subject
|
|
670
|
|
|
‡a
Author's Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: a single-center, Phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects
|
|
909
|
|
|
‡a
(scopus) 35880539100
‡9
1
|
|
909
|
|
|
‡a
(orcid) 0000000157998404
‡9
1
|
|
919
|
|
|
‡a
pharmacokineticpharmacodynamicinteractionbetweenbia3202anovelcomtinhibitorandlevodopacarbidopa
‡A
Pharmacokinetic-pharmacodynamic interaction between BIA 3-202, a novel COMT inhibitor, and levodopa/carbidopa
‡9
1
|
|
919
|
|
|
‡a
invivoevaluationofprolongedreleasebilayertabletsofantiparkinsondrugsingottingenminipigs
‡A
In-vivo evaluation of prolonged release bilayer tablets of anti-Parkinson drugs in Göttingen minipigs
‡9
1
|
|
919
|
|
|
‡a
pharmacokineticpharmacodynamicinteractionbetweenbia3202anovelcomtinhibitorandlevodopabenserazide
‡A
Pharmacokinetic-pharmacodynamic interaction between BIA 3-202, a novel COMT inhibitor, and levodopa/benserazide
‡9
1
|
|
919
|
|
|
‡a
pharmacokineticpharmacodynamicinteractionbetweennebicaponeandcontrolledreleaselevodopabenserazideasinglecenterphase1doubleblindrandomizedplacebocontrolled4waycrossoverstudyinhealthysubjects
‡A
Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: a single-center, Phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects
‡9
1
|
|
919
|
|
|
‡a
pharmacokineticpharmacodynamicinteractionbetweennebicaponeanovelcatecholomethyltransferaseinhibitorandcontrolledreleaselevodopacarbidopa200mg50mgrandomizeddoubleblindplacebocontrolledcrossoverstudyinhealthysubject
‡A
Pharmacokinetic-pharmacodynamic interaction between nebicapone, a novel catechol-o-methyltransferase inhibitor, and controlled-release levodopa/carbidopa 200 mg/50 mg: randomized, double-blind, placebo-controlled, crossover study in healthy subject
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
BLBNB|001558353
|
|
996
|
|
|
‡2
ISNI|0000000068009539
|
|
996
|
|
|
‡2
PTBNP|1188693
|
|
996
|
|
|
‡2
BIBSYS|90607696
|
|
996
|
|
|
‡2
LC|n 2006211542
|
|
996
|
|
|
‡2
RERO|A012795341
|
|
996
|
|
|
‡2
DNB|1297267095
|
|
996
|
|
|
‡2
SUDOC|168090945
|
|
996
|
|
|
‡2
ISNI|0000000032137811
|
|
996
|
|
|
‡2
PTBNP|139407
|
|
996
|
|
|
‡2
ISNI|0000000040973027
|
|
996
|
|
|
‡2
ISNI|0000000418121054
|
|
996
|
|
|
‡2
LC|n 81044594
|
|
996
|
|
|
‡2
ISNI|0000000374296767
|
|
996
|
|
|
‡2
ISNI|0000000068683785
|
|
996
|
|
|
‡2
LC|n 93054813
|
|
996
|
|
|
‡2
DNB|1060695022
|
|
996
|
|
|
‡2
DNB|1056240059
|
|
996
|
|
|
‡2
PTBNP|248206
|
|
996
|
|
|
‡2
J9U|987007315038905171
|
|
996
|
|
|
‡2
PTBNP|1709555
|
|
996
|
|
|
‡2
PTBNP|61537
|
|
996
|
|
|
‡2
NII|DA02542649
|
|
996
|
|
|
‡2
BLBNB|000350724
|
|
996
|
|
|
‡2
ISNI|0000000068517672
|
|
996
|
|
|
‡2
BLBNB|000368937
|
|
996
|
|
|
‡2
LIH|LNB:B6A_b_;=BB
|
|
996
|
|
|
‡2
LC|no2018114496
|
|
996
|
|
|
‡2
BLBNB|001427550
|
|
996
|
|
|
‡2
BNCHL|10000000000000000103612
|
|
996
|
|
|
‡2
LC|no2011162668
|
|
996
|
|
|
‡2
BIBSYS|90302389
|
|
996
|
|
|
‡2
PTBNP|92933
|
|
996
|
|
|
‡2
NUKAT|n 2005127043
|
|
996
|
|
|
‡2
PTBNP|1476816
|
|
996
|
|
|
‡2
BLBNB|000476897
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
